Edition:
United Kingdom

Eris Lifesciences Ltd (ERIS.NS)

ERIS.NS on National Stock Exchange of India

645.65INR
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
Rs645.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
34,940
52-wk High
Rs849.00
52-wk Low
Rs572.50

Summary

Name Age Since Current Position

Amit Bakshi

42 2016 Chairman of the Board, Managing Director

Sachin Shah

37 2016 Chief Financial Officer

Milind Talegaonkar

41 2016 Compliance Officer, Company Secretary

Inderjeet Negi

45 2016 Executive Director

Himanshu Shah

40 2016 Executive Director

Rajendrakumar Patel

39 2017 Head of Procurement

Kaushal Shah

37 2017 Head of Manufacturing and Distribution

Sanjiv Kaul

59 2011 Non-Executive Director - Nominee

Prashant Gupta

2018 Additional Independent Director

Vijaya Sampath

63 2017 Independent Director

Kirit Shelat

72 2017 Independent Director

Shanti Gopalkrishnan

2016 IR Contact Officer

Biographies

Name Description

Amit Bakshi

Mr. Amit Indubhushan Bakshi is Chairman of the Board, Managing Director of the Company. He has completed his basic education. Mr. Amit Indubhushan Bakshi has been on the Board of our Company since January 27, 2007 and was last reappointed with effect from April 1, 2016. He has previously worked with companies in the pharmaceutical sector in various capacities and has more than 10 years experience in the pharmaceutical industry. Mr. Amit Indubhushan Bakshi has been recognized as an ‘Entrepreneur of the Year, 2013’ by Ernst & Young.

Sachin Shah

Mr. Sachin Shah is Chief Financial Officer of the Company. Mr. Sachin Shah is a qualified chartered accountant and he holds a bachelor’s degree in commerce. He has been associated with our Company since January 1, 2013 as a Senior Manager – Finance and Processes. Pursuant to a Board resolution dated September 28, 2016, he was appointed as the Chief Financial Officer of our Company.

Milind Talegaonkar

Mr. Milind Talegaonkar is Compliance Officer, Company Secretary of the Company. He has been associated with our Company since May 2013. Mr. Milind Talegaonkar holds a bachelor’s degree in arts (management) from the Barkhatullah University, Bhopal. He holds a diploma in entrepreneurship administration and business laws from the West Bengal National University of Juridical Sciences. Mr. Milind Talegaonkar is an associate of the Institute of Company Secretaries of India. He has over sixteen years of experience in various fields, including corporate legal and secretarial compliances. Pursuant to a Board resolution dated September 6, 2016 he was appointed as our Company Secretary with effect from September 21, 2016 and pursuant to a Board resolution dated February 2, 2017, Mr. Milind Talegaonkar has been designated as our Compliance Officer. He has previously worked with L&T Infrastructure Development Projects Limited as an assistant manager, secretarial; and Indo Rama as assistant manager, licensing. He has also previously worked with HEG Limited as senior officer (finance).

Inderjeet Negi

Mr. Inderjeet Singh Negi is Executive Director of the Company. He holds a bachelor’s degree in science from Hemwati Nandan Bahuguna Garhwal University, Srinagar (Garhwal). He has previously worked with Intas Pharmaceuticals Limited as a regional sales manager. He has 13 years of experience in the pharmaceutical industry.

Himanshu Shah

Mr. Himanshu Jayantbhai Shah is Executive Director of the Company. He holds a bachelor’s degree in science from the Indira Gandhi National Open University. He also holds a diploma in pharmacy from Gujarat University and a diploma in management from the Indira Gandhi National Open University. He has previously worked with companies in the pharmaceutical sector in various capacities and has more than 10 years experience in the pharmaceutical industry.

Rajendrakumar Patel

Mr. Rajendrakumar Rambhai Patel is the Head of Procurement of the Company. He holds a bachelor’s degree in science from North Gujarat University and a diploma in pharmacy from the Gujarat University. He has previously worked with companies in the pharmaceutical sector and has more than 10 years experience in the pharmaceutical industry. Mr. Rajendrakumar Rambhai Patel currently is a director on the board of our Subsidiaries, Eris Therapeutics Private Limited and Kinedex Healthcare Private Limited.

Kaushal Shah

Mr. Kaushal Kamlesh Shah is the head of manufacturing and distribution of the Company. He holds a bachelor’s degree in commerce from the Gujarat University and a post graduate diploma in management from Som-Lalit Institute of Management Studies. He has more than 10 years experience in the pharmaceutical industry, having also have previously worked with companies in the pharmaceutical sector.Mr. Kaushal Kamlesh Shah has been associated with our Company since 2007 as one the directors on the Board. He resigned from the Board on January 5, 2017. Mr. Kaushal Kamlesh Shah currently is a director on the board of our Subsidiaries, Eris Therapeutics Private Limited and Kinedex Healthcare Private Limited.

Sanjiv Kaul

Mr. Sanjiv Dwarkanath Kaul is Non-Executive Director - Nominee of the Company. He holds a bachelor’s degree in pharmacy from the University of Bombay and a post graduate diploma in management from Indian Institute of Management, Ahmedabad. He has completed a course on Advance Management from Harvard University Graduate School of Business Administration, USA. He has been on our Board since August 29, 2011. He has previously worked with Ranbaxy for a period of 20 years. Mr. Sanjiv Dwarkanath Kaul has been associated with ChrysCapital Capital Advisors LLP since July 2004 and heads the healthcare and consumer departments of Chryscapital. He has over 25 years of experience in the pharmaceutical industry.

Prashant Gupta

Mr. Prashant Gupta serves as Additional Independent Director of the Company. Mr. Prashant Gupta is a Partner in the firm’s corporate department, focusing primarily on capital markets transactions. He represents both issuers and underwriters in various equity and debt capital raising transactions, including initial public offerings, rights issues and QIP offerings, buy-backs, capital restructurings and pre-IPO private placements. Prashant has been recognized by Who’s Who Legal, Chambers Asia, Indian Lawyer 250, Legal500 and other legal industry publications as one of the leading capital markets practitioners in India. He has also been selected by the Indian Business Law Journal as one of the top 100 lawyers in India in 2016 and 2017. Prashant has advised on capital markets transactions that have raised over US$30 billion globally. Several of the deals, as well as other transactions he has advised on, have been selected as ‘Deals of the Year’ by the International Financial Law Review (IFLR) Asia, India Business Law Journal, and the Asian-MENA Counsel Magazine. He has also acted on various international capital markets transactions by India focused companies, including the IPOs in the United States (NASDAQ/NYSE) by MakeMyTrip Limited, Azure Power Global Limited, Eros International plc, and Videocon d2h, as well as the reorganization and listing on the NYSE by Vedanta Limited. He has also advised on the buyback of shares by Infosys Limited, which was amongst the largest buybacks in India. He has advised the underwriters in the US$3.4 billion IPO by Coal India Limited in 2010, which has been the largest IPO in India and acted as sole Indian counsel for the US$1.7 billion bond offering by Vedanta Resources, which has been the largest bond offering by an Indian group. Prashant received his Bachelor of Arts in Jurisprudence and Master of Arts in Jurisprudence from the University of Oxford, England, and a Bachelor of Commerce from the Shri Ram College of Commerce, University of Delhi.

Vijaya Sampath

Ms. Vijaya Sampath is Independent Director of the Company. She holds a bachelor’s degree in arts from the University of Madras and a bachelor’s degree in law from the University of Mysore. She is a fellow member of the Institute of Company Secretaries of India. Ms. Vijaya Sampath also holds a certificate on advanced management program from Harvard University Graduate School of Business Administration, USA and a certificate on managing strategic alliances program from the University of Pennsylvania. Ms. Sampath has previously worked with the Indian Aluminium Company. She was also associated with Bharti Airtel Limited for eight years. At the time of resigning from Bharti Airtel Limited, she held the designation of Group General Counsel and Company Secretary. At present, she holds the designation of a senior partner in Lakshmikumaran and Sridharan, an Indian law firm. She has more than 15 years of experience in the legal profession.

Kirit Shelat

Dr. Kirit Nanubhai Shelat, (IAS retired) is an Independent Director of the Company. He holds a bachelor’s degree in arts (special) from the University of Gujarat and a Ph.D degree in public administration. Dr. Kirit Nanubhai Shelat has previously worked as the Commissioner of Rural Development, Industries Commissioner, Commissioner for Employment and Training and Commissioner for Disabled Persons. He was also the chairman of certain public undertakings including Gujarat Agro Industries Corporation and Land Development Corporation. He has 40 years of experience in public administration.

Shanti Gopalkrishnan